Skip to main content

Grafa News and Videos — Page 1624

Latest

Grafa
Health

enVVeno Medical narrows annual loss as focus shifts to enVVe™ FDA pivotal trial

enVVeno Medical (NASDAQ:NVNO), a clinical-stage medical device company developing innovative solutions for the treatment of chronic venous insufficiency (CVI), today reported its financial results for the full year ended December 31, 2025.

Read more: enVVeno Medical narrows annual loss as focus shifts to enVVe™ FDA pivotal trial

GET YOUR GRAFA EDGE NOW

We'll switch on a 30-day Edge trial as a welcome gift